APA (7th ed.) Citation

JJ, L., CD, T., J, B., Z, D., SL, V. D., N, E. R., . . . T, F. (2021). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clinical pharmacology and therapeutics, 109(6), 1417. https://doi.org/10.1002/cpt.2015

Chicago Style (17th ed.) Citation

JJ, Lima, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing." Clinical Pharmacology and Therapeutics 109, no. 6 (2021): 1417. https://doi.org/10.1002/cpt.2015.

MLA (9th ed.) Citation

JJ, Lima, et al. "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing." Clinical Pharmacology and Therapeutics, vol. 109, no. 6, 2021, p. 1417, https://doi.org/10.1002/cpt.2015.